SmithsonVery odd that Smithson had no options. How did Ivan expect to keep him?
Following the December 31, 2020 financial year end, on April 8, 2021, an aggregate total of 7,715,000 options were granted having an expiry date of April 8, 2026 with an exercise price of $1.00; and directors and NEOs receiving option grants were; Peter Dembicki (1,000,000); Ivan Bebek (700,000); Shawn Wallace (700,000); Steve Cook (200,000); Jeffrey Mason (200,000); Antonio Arribas (200,000); Paul Sun (200,000); Stacy Rowa (350,000); Elizabeth Senez (175,000). On April 29, 2021, an aggregate total of 200,000 options were granted having an expiry date of April 29, 2026 with an exercise price of $1.00; and directors receiving option grants were: Christina Strashek (200,000). On June 22, 2021 an aggregate total of 225,000 options were granted having an expiry date of June 22, 2026 with an exercise price of $1.44; there were no directors or NEOs who received options in this grant.